The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery

The screening of potential therapeutic compounds using phenotypic drug discovery (PDD) is being embraced once again by researchers and pharmaceutical companies as an approach to enhance the development of new effective therapeutics. Before the genomics and molecular biology era and the consecutive e...

Descripción completa

Detalles Bibliográficos
Autores principales: Segatto, Natalia V., Remião, Mariana H., Schachtschneider, Kyle M., Seixas, Fabiana K., Schook, Lawrence B., Collares, Tiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723300/
https://www.ncbi.nlm.nih.gov/pubmed/29259556
http://dx.doi.org/10.3389/fphar.2017.00894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723300/
https://www.ncbi.nlm.nih.gov/pubmed/29259556
http://dx.doi.org/10.3389/fphar.2017.00894

Ejemplares similares